J 2023

ELIXIR and Toxicology: a community in development [version 2; peer review: 2 approved]

MARTENS, Marvin, Rob STIERUM, Emma L. SCHYMANSKI, Chris T. EVELO, Reza AALIZADEH et. al.

Basic information

Original name

ELIXIR and Toxicology: a community in development [version 2; peer review: 2 approved]

Authors

MARTENS, Marvin, Rob STIERUM, Emma L. SCHYMANSKI, Chris T. EVELO, Reza AALIZADEH, Hristo ALADJOV, Kasia ARTURI, Karine AUDOUZE, Pavel BABICA, Karel BERKA, Jos BESSEMS, Luděk BLÁHA, Evan E. BOLTON, Montserrat CASES, Dimitrios Ε. DAMALAS, Kirtan DAVE, Marco DILGER, Thomas EXNER, Daan P. GEERKE, Roland GRAFSTRÖM, Alasdair GRAY, John M. HANCOCK, Henner HOLLERT, Nina JELIAZKOVA, Danyel JENNEN, Fabien JOURDAN, Pascal KAHLEM, Jana KLÁNOVÁ, Jos KLEINJANS, Todor KONDIC, Boï KONE, Iseult LYNCH, Uko MARAN, Sergio Martinez CUESTA, Hervé MÉNAGER, Steffen NEUMANN, Penny NYMARK, Herbert OBERACHER, Noelia RAMIREZ, Sylvie REMY, Philippe ROCCA-SERRA, Reza M. SALEK, Brett SALLACH, Susanna-Assunta SANSONE, Ferran SANZ, Haralambos SARIMVEIS, Sirarat SARNTIVIJAI, Tobias SCHULZE, Jaroslav SLOBODNIK, Ola SPJUTH, Jonathan TEDDS, Nikolaos THOMAIDIS, Ralf J.M. WEBER, Gerard J.P. VAN WESTEN, Craig E. WHEELOCK, Antony J. WILLIAMS, Hilda WITTERS, Barbara ZDRAZIL and Anže ŽUPANIČ

Edition

F1000Research, F1000 Research Ltd, 2023, 2046-1402

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10511 Environmental sciences

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Organization unit

Faculty of Science

Keywords in English

ELIXIR; FAIR; interoperability; Toxicology
Změněno: 23/2/2024 10:41, Mgr. Marie Šípková, DiS.

Abstract

V originále

Toxicology has been an active research field for many decades, with academic, industrial and government involvement. Modern omics and computational approaches are changing the field, from merely disease-specific observational models into target-specific predictive models. Traditionally, toxicology has strong links with other fields such as biology, chemistry, pharmacology, and medicine. With the rise of synthetic and new engineered materials, alongside ongoing prioritisation needs in chemical risk assessment for existing chemicals, early predictive evaluations are becoming of utmost importance to both scientific and regulatory purposes. ELIXIR is an intergovernmental organisation that brings together life science resources from across Europe. To coordinate the linkage of various life science efforts around modern predictive toxicology, the establishment of a new ELIXIR Community is seen as instrumental. In the past few years, joint efforts, building on incidental overlap, have been piloted in the context of ELIXIR. For example, the EU-ToxRisk, diXa, HeCaToS, transQST, and the nanotoxicology community have worked with the ELIXIR TeSS, Bioschemas, and Compute Platforms and activities. In 2018, a core group of interested parties wrote a proposal, outlining a sketch of what this new ELIXIR Toxicology Community would look like. A recent workshop (held September 30th to October 1st, 2020) extended this into an ELIXIR Toxicology roadmap and a shortlist of limited investment-high gain collaborations to give body to this new community. This Whitepaper outlines the results of these efforts and defines our vision of the ELIXIR Toxicology Community and how it complements other ELIXIR activities.

Links

733032, interní kód MU
Name: European Human Biomonitoring Initiative (Acronym: HBM4EU)
Investor: European Union, Health, demographic change and wellbeing (Societal Challenges)
825712, interní kód MU
Name: An integrative strategy of testing systems for identification of EDs related to metabolic disorders (Acronym: OBERON)
Investor: European Union, Health, demographic change and wellbeing (Societal Challenges)
859891, interní kód MU
Name: Best chemical risk assessment professionals for maximum Ecosystem Services benefit (Acronym: PRORISK)
Investor: European Union, MSCA Marie Skłodowska-Curie Actions (Excellent Science)